The dramatic increase in uterine growth during late pregnancy and the generation of labor contractions require dynamic remodeling of myometrial smooth muscle-ECM interactions. In many tissues, such interactions are provided by focal adhesions; however, there are no data as to the expression of focal adhesion proteins or of focal adhesion signaling in the myometrium. In this study, we show that tyrosine phosphorylation of myometrial FAK (FAK-P-Tyr) and of its downstream substrate, paxillin, exhibited a Ͼ10-fold increase during late pregnancy (days 15-22 of pregnancy) with each exhibiting a dramatic fall in P-Tyr on day 23 in association with the onset of labor. These changes in FAK-P-Tyr were paralleled by changes in FAK enzyme activity. Activated ERK1 and ERK2 expression remained relatively unchanged from day 15 to day 23, but decreased markedly 1 day post partum. Treatment of late pregnant rats with progesterone prevented the fall in FAK-P-Tyr/enzyme activity on day 23, and also blocked the onset of labor. These data suggest that progesterone (which decreases at term) modulates myometrial FAK activity/focal adhesion signaling and that these changes may underlie the tremendous remodeling that must occur in order for this muscle to develop optimal contractile activity during labor. (Endocrinology 141: 274 -283, 2000) 
T HE ONSET of labor is normally under precise temporal
control, so as to ensure the timely delivery of a term fetus whose organ systems are sufficiently mature for survival in the extrauterine environment. However, in about 5-10% of pregnancies, the onset of labor occurs preterm and results in significant mortality and morbidity amongst the premature neonate. While the precise mechanisms that lead to term or preterm birth remain to be determined, the signals that initiate labor are known to reside in the fetal genome. These signals ultimately lead to a switch in the phenotype of the uterine muscle, the myometrium, from a muscle which during pregnancy is quiescent and inactive to one which is spontaneously active, excitable, highly responsive to uterine agonists, and exhibits a high degree of cell-cell coupling. We have termed this switch in phenotype activation. Activation results from the increased expression of a cassette of genes that encode proteins such as ion channels, agonist receptors, and gap junctions and are collectively termed "contractionassociated proteins" or CAPs (1) .
Studies by numerous laboratories, including our own, have shown that activation requires triggering of two signaling pathways in the fetus. The first requires activation of an endocrine cascade involving the fetal hypothalamic-pituitary-adrenal-placental axis, the ultimate output of which in most species leads to a fall in circulating levels of progesterone and an increase in estrogen. While necessary, this endocrine pathway is not sufficient to bring about myometrial activation, and we have recently demonstrated that mechanical tension (or stretch) within the myometrium (as a result of fetal growth during pregnancy) is also required (2) . Importantly, under normal circumstances, premature activation of the myometrium by stretch is prevented by growth of the uterus, which itself is stimulated by fetal growth under the influence of progesterone. This involvement of mechanical signals in the growth of the uterus and in the process of myometrial activation at the onset of labor requires a mechanism by which uterine myocytes can both sense the mechanical signal and also generate biochemical responses to these signals.
In many tissues, focal adhesions have been postulated as providing the means for mechanotransduction. Focal adhesions are comprised of clusters of integrins at sites where the cell makes contact with the extracellular matrix substratum (3) (4) (5) . These adhesions or contacts are potential sites for protein tyrosine kinase mediated regulation of cell behavior such as cell spreading, migration, and anchorage-dependent survival and proliferation (5) . Proteins such as focal adhesion kinase (FAK), c-src (Src), paxillin, vinculin, as well as proteins such as GRB2, talin, ␣-actinin, and tensin are known to associate at focal adhesion sites (6) . Among these proteins, FAK is believed to play a critical role in modulating formation and turnover of focal adhesions. FAK is a 125-kDa cytoplasmic tyrosine kinase that was first described as a putative substrate for pp60 v-src (7, 8) , an oncogenic retrovirus gene product. It is broadly expressed in cell lines, but there is a paucity of information regarding its expression in tissues in vivo. FAK can form a signaling complex with Src, a member of the Src family of cytoplasmic tyrosine kinases, and signaling can lead to activation of downstream enzymes such as MAPK (9) . Src binds FAK via its SH2 domain (6) , and Src kinase activity appears to be necessary for focal adhesion turnover but dispensable for translocation to focal adhesions (10) .
Integrin binding has been reported to induce/coordinate tyrosine phosphorylation (P-Tyr) of FAK and of its substrate, paxillin, in a number of cell types (7, 8, 11, 12) . Paxillin is a 68-kDa adaptor protein that may have regulatory and structural roles. Tyrosine phosphorylation of paxillin by FAK is thought to recruit SH2 domain-containing proteins such as vinculin, a 117-kDa protein that is highly concentrated in focal adhesions and smooth muscle dense plaques (6) . Vinculin also binds F-actin (13) , therefore this may allow a physical as well as biochemical link between focal adhesions and the cytoskeleton. Changes in vinculin expression appear to have serious consequences on cellular attachment and motility (6).
FIG. 1. Immunoblot detection of vinculin (A), Src (B)
, FAK (C), and paxillin (D) in rat myometrium during late pregnancy. Immunoblot results were quantified by densitometry, and error bars represent SEM (n ϭ 4 for vinculin and Src; n ϭ 5 and n ϭ 6 for FAK and paxillin, respectively). No significant differences in expression were found for vinculin or Src during gestation but FAK expression was significantly higher at day 22 and 1dPP compared with day 15 (*; P Ͻ 0.05). FAK levels were also significantly higher at 1dPP than day 23 of gestation (ϩ; P Ͻ 0.05). Paxillin levels were significantly higher at 1dPP compared with day 22 and day 23 (*; P Ͻ 0.05).
During late pregnancy and especially at labor, adhesion of myometrial cells to the extracellular matrix is critical for myometrial growth and for the development of the intense, coordinated contractions of labor. With the exception of some integrins (14) , there have been no published reports of focal adhesion-associated proteins detected in the myometrium of the uterus. Our intent was thus to 1) characterize the expression and/or tyrosine phosphorylation (or activity) of FAK, paxillin, vinculin and Src in the myometrium of the rat during late pregnancy; 2) determine whether changes in expression/phosphorylation of focal adhesion proteins were linked to the onset of labor; and 3) to investigate the mechanisms that might control these events. We report for the first time that not only are there dramatic changes in activity of FAK and its substrates in the myometrium during late pregnancy and with the onset of labor, but that the steroid hormone, progesterone, is an important modulator of FAK activity.
Materials and Methods Animals
Wistar rats (Charles River Laboratories, Inc., St. Constance, Canada) were individually housed under standard environmental conditions (12-h light, 12-h dark) and fed a Purina diet (Ralston Purina Co., St. Louis, MO) and water ad libitum. All experiments were approved by the institutional animal care committee. Wistar rats (ϳ250 g each) were 23 , and (E) 1dPP. A secondary antibody control was also completed on day 22 myometrium (F). Five-micrometer-thick sections of rat myometrium were incubated with an FAK-specific antisera and imaged with a laser scanning confocal microscope. FAK was localized both to areas of cell/ECM contact (small arrows) and to perinuclear regions of myocytes (large arrows). Scale bar, 50 m. mated and the day of observation of a vaginal plug was designated day 1 post coitum. The time of delivery under these standard conditions was day 23 of gestation.
Tissue collection
All animals were killed by carbon dioxide inhalation on day 15, 21, 22, 23, and 1 day post partum (1dPP). The uterine horns were removed, placed in ice-cold saline, and opened longitudinally. The endometrium was carefully removed by scraping the luminal surface of the uterus, and myometrial tissue was flash-frozen in liquid nitrogen and stored at Ϫ70 C. Samples were not pooled. The number of animals analyzed on each day of gestation (n) is documented in the legend of each figure.
Dynamics of focal adhesion protein expression during pregnancy and labor

SDS-PAGE and Western blotting.
Frozen rat myometrial samples were pulverized under liquid nitrogen with a mortar and pestle and homogenized in RIPA lysis buffer [50 mm Tris-HCl (pH 7.5), 150 mm NaCl, 1% (vol/vol) Triton X-100, 1% (wt/vol) sodium deoxycholate, 0.1% (wt/vol) SDS, 100 m Na 2 VO 3 and COMPLETE, Mini EDTA-free protease inhibitors (Roche Molecular Biochemicals , Laval, Québec, Canada)]. Samples were centrifuged at 15,000 ϫ g at 4 C for 15 min and the supernatants collected. Protein concentrations were determined by the Bradford Assay (15) using Bio-Rad Laboratories, Inc. protein assay dye reagent (Bio-Rad Laboratories, Inc. Mississauga, Ontario, Canada). Protein samples (100 g/lane) were separated by PAGE according to the method of Laemmli (16), using 4 -12% gradient polyacrylamide gels (Helixx Technologies, Scarborough, Ontario, Canada). All protein sample sets were checked for equal loading with Coomasie Blue staining. Protein samples were electroblotted to 0.45 m polyvinylidene difluoride (PVDF) membrane (Millipore Corp. Canada, Nepean, Ontario, Canada).
PVDF membranes were rinsed in methanol for 10 s then rehydrated in tap distilled water for 3 min. Unless otherwise stated, all incubations were done at room temperature and with constant agitation. Blots were blocked in 5% skim milk powder for 1 h (5% BSA for detection of phosphotyrosines), rinsed 1 ϫ 15 min in Tris-buffered saline (20 mm Tris base, 137 mm NaCl, pH 7.6) with 0.1% Tween-20 (TBST) and 2 ϫ 5 min in TBST. Primary antisera were diluted in blocking solution and incu-
Immunocytochemical localization of FAK in the longitudinal muscle of the rat myometrium during (A) day 15, (B) day 21, (C) day 22, (D) day 23, and (E) 1dPP. A secondary antibody control was also completed on day 22 myometrium (F). Five-micrometer-thick sections of rat myometrium were incubated with an FAK-specific antisera and imaged with a laser scanning confocal microscope. FAK was localized both to areas of cell/ECM contact (small arrows) and to perinuclear regions of myocytes (large arrows). Scale bar, 50 m.
bated with blots for 1 h or overnight at 4 C. Membranes were rinsed 1 ϫ 15 min in TBST, followed by two more washes for 5 min in TBST. Appropriate secondary antisera, conjugated to horseradish peroxidase (Amersham Pharmacia Biotech, Baie d'Urfé, Québec, Canada), were also diluted in blocking solution and incubated with membranes for 1 h. Membranes were washed 1 ϫ 15 min in TBST then 4 X 5 min in TBST. Proteins were detected using the Amersham Pharmacia Biotech ECL detection system and multiple exposures were generated to ensure the linearity of the film exposures.
Antisera. Rabbit polyclonal antisera raised against FAK, Src and phosphotyrosines (PY99) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). A polyclonal antisera raised against activated MAPK (ERK1 and 2) was obtained from Promega Corp. (Promega Corp., Madison, WI). Monoclonal antisera to vinculin and paxillin were purchased from Upstate Biotechnology, Inc. (Lake Placid, NY) and Transduction Laboratories (Bio/Can Scientific, Mississauga, Ontario, Canada) respectively. FITC-conjugated goat antirabbit IgG was purchased from Zymed Laboratories, Inc. (Markham, Ontario, Canada).
Immunoprecipitations
Prewashing Protein-A Sepharose 4B. Protein-A Sepharose 4B (Zymed Laboratories, Inc.) was washed with 5-10 ϫ volumes of cold RIPA buffer, vortexed, and centrifuged at 2500 rpm for 1 min. The supernatant was discarded and the pellet resuspended in the original volume of RIPA buffer.
Immunoprecipitation. Four hundred microgram protein samples were diluted in RIPA buffer to a concentration of 1 g/l (i.e. 400 l for 400 g), then precleared with 20 l of Protein-A Sepharose 4B for 30 min at 4 C on a nutator. Samples were centrifuged at 1500 rpm at 4 C for 1 min, the supernatants were retained on ice and the pellet discarded. 1 g of antisera was added to each sample and the mixtures incubated at 4 C on a nutator overnight. 20 l of Protein-A Sepharose 4B was added to each lysate and incubated at 4 C for 1 h or overnight on a rotator. Precipitates were collected by centrifugation at 2500 rpm for 5 min and supernatants were collected and discarded. The Sepharose 4B pellets were washed 4 times with 0.5 ml RIPA buffer with repeated centrifugations at 2500 rpm. The final pellets were resuspended in 1 ϫ SDS loading buffer, boiled 3 min, centrifuged, and analyzed by PAGE and Western blotting.
FAK kinase assays. FAK kinase assays were based primarily on a protocol by Guan and Shalloway (17) . Immunoprecipitated FAK samples, bound to protein-A beads, were washed twice with 1 ϫ kinase buffer (20 mm HEPES, pH 7.5, 10 mm MnCl 2 , 1 mm DTT). Thirty microliters of Poly Glu,Tyr (4:1) substrate beads (Sigma, St. Louis, MO) were used per kinase reaction. The substrate beads were washed once with 1 ϫ kinase buffer then added to 2 l (20 Ci) of ␥-32 P-ATP and 8 l of 2 ϫ kinase buffer (40 mm HEPES, pH 7.5, 20 mm MnCl 2 , 2 mm DTT). The substrate mixture was added to FAK/protein A beads and incubated at 30 C for 20 min. Reactions were terminated with the addition of 2 ϫ SDS loading buffer and samples run on 8 -16% polyacrylamide gels. Gels were dried and exposed to a phosphoimaging screen.
Src kinase assays. Ten micrograms of enolase (Sigma) per reaction was acid denatured with 1 volume of acetic acid for 5 min at 30 C then neutralized with 1 ⁄2 volume of 1 m HEPES (pH 7.4) buffer. An equal volume of 2ϫ kinase buffer (40 mm HEPES, pH 7.5, 20 mm MnCl2, 2 mm DTT) was added, followed by 10 Ci of ␥-32 P-ATP. This reaction buffer was added to protein-A Sepharose beads, complexed to immunoprecipitated Src, that had been washed twice in 1 ϫ kinase buffer. Kinase reactions were performed at 30 C for 15 min. Reactions were terminated with the addition of 2 ϫ SDS-loading dye and analyzed on polyacrylamide gels. Gels were stained with Coomasie Blue and dried before exposure in a phosphoimaging cassette. Densitometric analysis of images was performed with Storm 860 phosphoimaging software (Molecular Dynamics, Inc.).
Paraffin embedding. Rat uteri were fixed in 4% paraformaldehyde in PBS overnight at 4 C with constant agitation. Tissues were rinsed with two washes of cold PBS and then dehydrated for one hour each through a graded series of ethanol (70%, 80%, 90%, 95%, 100%). Samples were cleared in xylene for 1 h and then infiltrated in paraffin overnight at 60 C. Uteri were then placed in moulds containing fresh paraffin before cooling.
Immunofluorescence detection of FAK. Five micrometer thick paraffin sections of rat uteri, from various stages of late pregnancy, were placed on SUPERFROST Plus (Fisher Scientific Ltd., Nepean, Ontario, Canada) slides and dried at 37 C overnight. Sections were dewaxed in xylene, rehydrated in descending grades of ethanol, and finally soaked in PBS. Tissues were permeabilized in 0.125% Trypsin in PBS for 10 min at room temperature and rinsed in PBS. Sections were blocked in 5% normal goat serum/1% BSA for 30 min at room temperature. Rabbit anti-FAK, at a dilution of 1:250, was used as a primary antibody and sections incubated overnight with antibody at 4 C. Tissue sections were rinsed in PBS and incubated for 1 h with FITC conjugated antirabbit IgG, at a dilution of 1:100, at room temperature on a shaker. Tissues were washed in cold PBS containing 0.02% Tween 20 and mounted in Vectashield (Vector Laboratories, Inc., Burlington, Ontario, Canada) before observation on an MRC-600 laser scanning confocal microscope (Bio-Rad Laboratories, Inc.).
Hormonal modulation of myometrial-cytoskeletal signaling
Progesterone-delayed labor experiments. The onset of labor is associated with a withdrawal of the inhibitory effects of progesterone on the myometrium consequent on a fall in plasma levels of this steroid. To determine whether progesterone withdrawal might modulate focal adhesion signaling, rats were randomized to receive either a daily injection of progesterone (4 mg, sc, in 0.2 ml corn oil) to maintain elevated plasma levels of this steroid or vehicle alone (corn oil, 0.2 ml sc) beginning on day 20 of gestation (18) . Control animals were killed on day 21, day 22, and day 23 (during delivery). Progesterone-treated rats were killed at the same gestation days; however, on day 23 the rats were not in labor (since progesterone blocks the normal onset of labor on day 23). Myometrial samples were taken as described above. Focal adhesion signaling was monitored by analysis of FAK P-Tyr/kinase activity.
Statistical analysis
Densitometric data were expressed as the mean densitometric units Ϯ sem. Data were subjected to a one-way ANOVA, followed by a Bonferroni or Student-Newman-Keul's method multiple comparison test to determine between-group differences. The level of significance used was P Ͻ 0.05.
Results
Detection of focal adhesion complex components
To identify proteins of focal adhesion-associated complexes that may be present in the myometrium, Western blots of rat myometrial protein extracts from days 15, 21, 22, 23, and 1 day post partum (1dPP) gestation were probed with antisera specific to FAK, paxillin, Src, and vinculin. Each of these proteins was found to be present in the pregnant rat myometrium. Although expression of vinculin and Src did not change across gestational age (Fig. 1, A and B) , statistically significant (P Ͻ 0.05) changes were detected in the expression of FAK and paxillin. FAK expression significantly increased 3-fold (Fig. 1C) between days 15 and 22 of gestation. In addition, FAK expression at 1dPP was 4-fold greater than day 15 and 2-fold greater than day 23. Paxillin levels at 1dPP were also significantly higher, increasing 1.9-and 1.7-fold over day 22 and day 23 gestation stages respectively (Fig.  1D) .
Immunofluorescence detection of FAK in rat uteri
FAK expression was barely detectable in circular and longitudinal layers of day 15 rat myometrium ( Figs. 2A and 3A) . Greater expression was detected, however, from day 21 onwards in both layers (Figs. 2, B-E, and 3 , B-E). FAK was detected in both cell/ECM contact sites and perinuclear re-FIG. 5. Determination of (A) FAK, (B) paxillin, and (C) Src activation during late pregnancy. FAK, paxillin, and Src were immunoprecipitated from day 15, day 21, day 22, day 23, and 1dPP rat myometrial lysates. FAK and paxillin immunoprecipitates were analyzed by SDS-PAGE, immunoblotted and probed with phosphotyrosine-specific antisera while Src immunoprecipitates were used for in vitro kinase assays with enolase. All results were analyzed by densitometry, and above each FAK and paxillin graph is an example of one immunoblot (A, B). Error bars represent SEM (n ϭ 3). FAK and paxillin P-Tyr levels on days 21 and 22 were significantly elevated over all remaining gestation times (*; P Ͻ 0.05).
gions of myocytes (Fig. 4) . In circular muscle layers at day 23, however, FAK was primarily localized to perinuclear regions (Fig. 2D) . In the longitudinal muscle of the myometrium, FAK was detectable in regions of close cell/ECM contact (Fig. 3, B and C, E), but at day 23, longitudinal muscle also contained significant amounts of FAK in perinuclear regions of myocytes (Fig. 3D) .
Detection of tyrosine phosphorylated FAK and paxillin
Tyrosine phosphorylation of focal adhesion-associated proteins such as FAK and paxillin is considered to indicate an activated state of the protein and may be more informative of their role in focal adhesion function. Consequently, FAK and paxillin were immunoprecipitated from samples of pregnant myometrium (day 15 to 1day PP) and analyzed for phosphotyrosine (P-Tyr) content. FAK P-Tyr content increased Ͼ10-fold from day 15 to day 21 and then dropped 75% on day 23 ( Fig. 5A ) during labor and delivery of the fetuses (day 23). FAK kinase assays with an exogenous substrate confirmed that the observed FAK P-Tyr levels represented an active kinase (Fig. 6) . Because paxillin is a downstream substrate for FAK, we also analyzed the P-Tyr content of paxillin as a potential marker of the activation of a focal adhesion-cytoskeleton transduction pathway. Paxillin P-Tyr levels followed an almost identical pattern to FAK, increasing 4-fold between day 15 and day 21 and decreasing greater than 75% between day 21 and day 23 (Fig. 5B) . Src kinase activity did not significantly change throughout late pregnancy (Fig. 5C ).
Downstream targets of integrin-mediated signaling
A number of investigations have indicated that MAPK could be a potential downstream signaling component of integrin-mediated signaling (9, 19) . This signaling pathway could use FAK's Grb2 binding site in its focal adhesion targeting domain producing a FAK:Grb2:Ras:MAPK signaling cascade. Using an antisera that specifically binds to the active MAPKs, ERK1, and ERK2, we have found that expression of ERK1 (44 kDa) was significantly elevated during labor (day 23) compared with its expression during late pregnancy and postpartum (Fig. 7) . Expression of both ERK1 and ERK2 (42 kDa) was significantly elevated throughout late pregnancy compared with 1dPP when levels fell by 75-80%.
Modulation of FAK activity by progesterone.
Administration of progesterone to pregnant rats beginning at day 20 of gestation prevented the fall in FAK P-Ttyr and FAK kinase activity that occurred in control rats on day 23 (Figs. 8 and 9 ). Moreover, in these progesterone-treated rats in which the fall in FAK P-Tyr was blocked, labor did not occur.
Discussion
Our knowledge of focal adhesion organization and of the role that protein components of this complex play in focal adhesion remodeling and signaling are generally limited to studies on cultured cells or on in vitro protein interactions. In this report, we provide the first demonstration of an in vivo association between the expression and activation of proteins known to regulate ECM-cytoskeletal signaling and a major physiologic process, namely the onset of labor. Moreover, we provide evidence of a novel mechanism of FAK activation/ phosphorylation involving the steroid hormone progesterone.
Expression of focal adhesion proteins during late pregnancy
FAK, paxillin, Src, and vinculin were all detected by Western blot analysis in the rat myometrium during late pregnancy, but only FAK and paxillin displayed significant changes in expression with levels continuing to increase FIG. 7 . Activated MAPK expression in rat myometrium during late pregnancy. Immunoblots containing rat myometrial protein from day 15, day 21, day 22, day 23, and 1dPP were probed with an antisera specific to activated ERK1 and ERK2. Immunoblot results were quantified by densitometry and above the densitometric analysis is an example of one immunoblot. Error bars represent SEM (n ϭ 4). Activated ERK1 expression was significantly elevated during late pregnancy compared with 1dPP (ϩ; P Ͻ 0.05) and in particular at day 23 ERK1 was significantly elevated over all remaining gestation times (F; P Ͻ 0.05). Activated ERK2 levels at day 15, day 21, day 22, and day 23 were significantly higher than 1dPP (*; P Ͻ 0.05).
FIG. 6. Determination of FAK kinase activity with an exogenous substrate during normal gestation. FAK was immunoprecipitated from day 15, day 21, day 22, day 23, and 1dPP rat myometrial lysates and used for in vitro kinase assays with Poly Glu, Tyr (4:1). Kinase reactions were analyzed by SDS-PAGE and exposed to a phosphoimaging screen. Bands observed at 125 kDa are autophosphorylated FAK, whereas bands at 50 kDa represent phosphorylated substrate (see arrows).
through postpartum. The postpartum period is a time of considerable change in the uterus, and in particular the myometrium, as this tissue undergoes a process of dramatic remodeling (termed involution) as it reverts to the nonpregnant state (20) . Involution involves considerable apoptosis, subsequent cell growth and remodeling, processes that require reorganization of ECM-cytoskeletal interactions at focal adhesions. In other systems, FAK and paxillin have been implicated in the reorganization of focal adhesions particularly during cell migration (21) and it is possible that they play a similar role in the myometrium.
Modulation of FAK-P-Tyr and enzyme activity during late pregnancy and the onset of labor
The tyrosine phosphorylation of focal adhesion-associated proteins is of fundamental importance for regulating enzymatic activity and protein-protein interactions. We found a dramatic increase in FAK P-Tyr and enzyme activity between days 15 and 22, a time when we have shown that the myometrium is undergoing maximal hypertrophy (Gleicher and Lye, unpublished observations) likely as a consequence of exponential increases in fetal growth. This period of late pregnancy is also a time when there is substantial remodeling of the ECM, including increased collagenolysis, the formation of elastic fibres within the circular muscle of the myometrium, as well as marked increases in fibronectin localization and thickness of continuous basement membranes (22) . Investigation of mice carrying a null mutation in the fak gene suggest a positive association between FAK P-Tyr/ activity and the rate of focal adhesion turnover (23) . While this mutation results in embryonic lethality, fibroblasts from fak Ϫ/Ϫ null embryos, when grown in tissue culture, exhibit very large focal adhesions and significantly reduced cell migration, suggesting decreased focal adhesion turnover. Thus the elevated FAK P-Tyr during late pregnancy might mediate focal adhesion turnover and hence support growth (hypertrophy) of the myometrium at this time.
The decrease in FAK phosphotyrosine content at day 23 suggest that focal adhesions are stabilized. This may be necessary for efficient and coordinated labor contractions to 9 . Determination of FAK kinase activity with an exogenous substrate during progesterone-delayed labor. FAK was immunoprecipitated from day 21, day 22, and day 23 progesterone-delayed labor or vehicle control rat myometrial lysates. Immunoprecipitates were used for in vitro kinase assays with Poly Glu, Tyr (4:1). Kinase reactions were analyzed by SDS-PAGE and exposed to a phosphoimaging screen. Bands observed at 125 kDa are autophosphorylated FAK, whereas bands at 50 kDa represent phosphorylated substrate (see arrows).
occur. In addition, because considerable FAK is detected in perinuclear regions of myocytes at day 23 and no cleaved forms of FAK, due to caspase activity (21) , were detected on Western blots (data not shown), this perinuclear localization may represent newly synthesized FAK in the endoplasmic reticulum. It is possible that FAK is involved in additional function(s) during labor and in the postpartum period. Work by Frisch et al. (24) and Hungerford et al. (25) have shown that decreased FAK activity may be associated with increased apoptosis. Therefore, FAK deactivation near or at the termination of pregnancy may facilitate apoptosis within the myometrium and contribute to the involution process.
Our observation that exogenous administration of progesterone maintains elevated FAK P-Tyr levels and kinase activity on day 23 (when FAK P-Tyr normally falls) is the first indication that the level of tyrosine phosphorylation of FAK may be modulated by steroid hormones, in this case progesterone. These data also suggest that the decrease in FAK P-Tyr and enzyme activity with the onset of labor on day 23 is likely due to the endogenous fall in plasma progesterone levels that occurs at this time (1, 26) . The mechanisms underlying this effect remain to be determined. One might speculate that, in the present study, progesterone may have modified the expression (or indirectly the activity) of a kinase for which FAK is a substrate. Because progesterone administration blocks the increase in estrogen normally seen during labor, it is also possible that the decrease in FAK activation is due to an action of estrogen (perhaps through induction of a phosphatase). Whatever the mechanism, these data provide an interesting area for future investigation.
The possible importance of focal adhesion assembly and signaling to physiologic events such as labor was underscored by the observation that in rats treated with progesterone not only was the elevated level of FAK P-Tyr and enzyme activity maintained but that labor was delayed in all of these animals.
FAK activation and downstream signaling
FAK activation has consequences on two major systems within the cell; the recruitment and formation of the focal adhesion-cytoskeleton complex, and the activation of downstream intracellular signaling pathways. Paxillin is a substrate of FAK (11) and the close association between its increased phosphorylation and the increase in FAK P-Tyr and enzyme activity around day 20 -22 is consistent with FAK activation-induced paxillin phosphorylation within the myometrium at this time. In its phosphorylated state, paxillin can interact with other proteins, such as vinculin, through SH2 adaptor domains to coordinate assembly of the focal adhesion-cytoskeleton complex (11, 27) . Interactions between FAK and other kinases (e.g. Src at the Tyr 397 site) leads to activation of signaling pathways (e.g. MAPK pathway). Active ERK1 and ERK2 are present in myometrial cells during late pregnancy to act as potential targets of signaling initiated by FAK. In the present study, we found no major change in Src kinase activity during the period of maximal FAK activation. However, it would be premature to suggest that interactions between FAK and Src are not occurring at this time because in this study we analyzed total cellular Src rather than that component that is associated with FAK.
FAK activation and the onset of labor
The onset of labor is associated with remarkable changes in myometrial function, with this muscle switching from a state of quiescence during pregnancy to intense activity during labor. This activation process is characterized by the increased expression of a cassette of genes encoding contraction-associated proteins or CAPs, including gap junctions, agonist receptors, and ion channels that confer increased contractility to this muscle. Recent work from this laboratory suggests that the increased expression of these CAPs requires both endocrine (estrogen and progesterone) and mechanical (uterine stretch due to fetal growth) signals. Several investigators have shown that increasing mechanical strain on vascular endothelial cells or vascular smooth muscle cells activates integrin-mediated signaling through focal adhesion complexes (9, 28, 29) . In addition, stretching of mesangial cells has been shown to increase FAK tyrosine phosphorylation, coincident with increased production of ECM proteins such as fibronectin, collagen, and laminin (30) . It is possible that stretch of uterine myocytes during late pregnancy might also modulate myometrial FAK expression/activity.
Our data suggest a role for FAK in the onset of labor. We speculate that during late pregnancy, fetal growth imposes mechanical tension on the myometrium, which in turn induces activation of FAK leading to focal adhesion turnover and supporting myometrial cell hypertrophy. The resulting growth of the myometrium acts to attenuate the tension induced by fetal growth. The fall in endogenous levels of progesterone at term leads to a fall in FAK P-Tyr/kinase activity, stabilization of focal adhesions (rather than turnover) and the cessation of myocyte hypertrophy. Because fetal growth continues, this places the uterine myocytes under significant tension leading to increased expression of CAPs, myometrial activation, and the onset of labor.
